Search research articles
Contact Us
Filters
Showing results (81-90 of 137) with videos related to
Page
of 14
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 11, 2013
High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010
Julia C Dombrowski, Mari M Kitahata, Stephen E Van Rompaey, et al.
Plos One
|
February 26, 2013
Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers
Gareth A D Hardy, Scott Sieg, Benigno Rodriguez, et al.
International Journal of Epidemiology
|
February 12, 2008
Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems
Mari M Kitahata, Benigno Rodriguez, Richard Haubrich, et al.
The Journal of Infectious Diseases
|
July 10, 2020
Physical Function Impairment and Frailty in Middle-Aged People Living With Human Immunodeficiency Virus in the REPRIEVE Trial Ancillary Study PREPARE
Triin Umbleja, Todd T Brown, Edgar T Overton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 10, 2016
Brief Report: Elevated Red Cell Distribution Width Identifies Elevated Cardiovascular Disease Risk in Patients With HIV Infection
Sadeer G Al-Kindi, Chang H Kim, Stephen R Morris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 5, 2014
Current practices of screening for incident hepatitis C virus (HCV) infection among HIV-infected, HCV-uninfected individuals in primary care
J Morgan Freiman, Wei Huang, Laura F White, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 3, 2015
Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV Infection
Carey L Shive, Brian Clagett, Marie R McCausland, et al.
Vaccine
|
December 20, 2017
Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection
Carey L Shive, Chelsey J Judge, Brian Clagett, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 31, 2013
Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial
Benigno Rodriguez, David M Asmuth, Roy M Matining, et al.
JCI Insight
|
May 6, 2020
Inflammescent CX3CR1+CD57+CD8+ T cells are generated and expanded by IL-15
Stephen R Morris, Bonnie Chen, Joseph C Mudd, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 137) with videos related to
Sort By:
Page
of 14
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 11, 2013
High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010
Julia C Dombrowski, Mari M Kitahata, Stephen E Van Rompaey, et al.
Plos One
|
February 26, 2013
Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers
Gareth A D Hardy, Scott Sieg, Benigno Rodriguez, et al.
International Journal of Epidemiology
|
February 12, 2008
Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems
Mari M Kitahata, Benigno Rodriguez, Richard Haubrich, et al.
The Journal of Infectious Diseases
|
July 10, 2020
Physical Function Impairment and Frailty in Middle-Aged People Living With Human Immunodeficiency Virus in the REPRIEVE Trial Ancillary Study PREPARE
Triin Umbleja, Todd T Brown, Edgar T Overton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 10, 2016
Brief Report: Elevated Red Cell Distribution Width Identifies Elevated Cardiovascular Disease Risk in Patients With HIV Infection
Sadeer G Al-Kindi, Chang H Kim, Stephen R Morris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 5, 2014
Current practices of screening for incident hepatitis C virus (HCV) infection among HIV-infected, HCV-uninfected individuals in primary care
J Morgan Freiman, Wei Huang, Laura F White, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 3, 2015
Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV Infection
Carey L Shive, Brian Clagett, Marie R McCausland, et al.
Vaccine
|
December 20, 2017
Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection
Carey L Shive, Chelsey J Judge, Brian Clagett, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 31, 2013
Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial
Benigno Rodriguez, David M Asmuth, Roy M Matining, et al.
JCI Insight
|
May 6, 2020
Inflammescent CX3CR1+CD57+CD8+ T cells are generated and expanded by IL-15
Stephen R Morris, Bonnie Chen, Joseph C Mudd, et al.
Page
of 14